Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free PPCB Stock Alerts

Propanc Biopharma (PPCB) Stock Chart & Stock Price History

Propanc Biopharma logo
$1.37 -0.08 (-5.52%)
Closing price 07/24/2026 04:00 PM Eastern
Extended Trading
$1.38 +0.01 (+1.02%)
As of 07/24/2026 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Propanc Biopharma Stock Price Performance

The Propanc Biopharma (PPCB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.07%, with a year-to-date return of -89.79%. In the past month, the stock has decreased 9.27%, reflecting recent market activity.

As of the latest close, Propanc Biopharma traded at $1.37 with a market cap of $3.12 million and volume of 13,245 shares. Five years ago, the stock traded at a split-adjusted price of $1,097.50, representing a 99.88% decrease over that period. At the time, it had a market cap of $342 thousand and a volume of 11 shares.

Receive PPCB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Propanc Biopharma and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-0.72%
1 Month
Performance
-9.27%
3 Month
Performance
-50.14%
Year-To-Date
Performance
-89.79%
1 Year
Performance
-99.07%
5 Year
Performance
-99.88%

PPCB Stock Chart for Saturday, July, 25, 2026

PPCB Chart by TradingView

Propanc Biopharma Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
07/24/2026$1.45$1.37
-5.52%		$1.46$1.3513,245 shs$3.12 million
07/23/2026$1.44$1.45
+0.69%		$1.53$1.4338,598 shs$3.31 million
07/22/2026$1.38$1.44
+4.35%		$1.47$1.36104,823 shs$3.28 million
07/21/2026$1.38$1.38$1.45$1.3547,881 shs$3.15 million
07/20/2026$1.49$1.38
-7.38%		$1.50$1.33105,872 shs$3.15 million
07/17/2026$1.59$1.49
-6.29%		$1.57$1.40148,390 shs$3.40 million
07/16/2026$1.63$1.59
-2.45%		$1.74$1.47323,181 shs$3.63 million
07/15/2026$1.63$1.63$1.69$1.60112,813 shs$3.71 million
07/14/2026$1.60$1.63
+1.87%		$1.67$1.5693,572 shs$3.72 million
07/13/2026$1.61$1.60
-0.62%		$1.63$1.5696,296 shs$3.65 million
A letter from Shannon Stansberry (Ad)

Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel

Watch the full story and see the verified track record for yourself
07/10/2026$1.78$1.61
-9.55%		$1.79$1.57218,210 shs$3.67 million
07/09/2026$1.80$1.78
-1.11%		$1.90$1.72207,297 shs$4.06 million
07/08/2026$1.82$1.80
-1.10%		$1.89$1.76194,558 shs$4.10 million
07/07/2026$1.88$1.82
-3.19%		$1.95$1.574.71 million shs$4.15 million
07/06/2026$1.77$1.88
+6.21%		$2.00$1.651.28 million shs$4.29 million
07/03/2026$1.77$1.77$2.47$1.5852.98 million shs$4.04 million
07/02/2026$1.44$1.77
+22.92%		$2.47$1.5852.98 million shs$4.03 million
07/01/2026$1.50$1.44
-4.00%		$1.56$1.4146,004 shs$3.28 million
06/30/2026$1.58$1.50
-5.06%		$1.57$1.4652,268 shs$3.42 million
06/29/2026$1.47$1.58
+7.48%		$1.60$1.47333,084 shs$3.60 million
06/26/2026$1.51$1.47
-2.65%		$1.50$1.4153,608 shs$3.35 million
06/25/2026$1.49$1.51
+1.34%		$1.55$1.44122,932 shs$3.44 million
06/24/2026$1.47$1.49
+1.36%		$1.53$1.40105,643 shs$3.40 million
Related Companies

This page (NASDAQ:PPCB) was last updated on 7/25/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Three oil giants buried the same discovery for 50 years
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel